Research any topic before you write.
Find related topics. | Discover entities. | See connections. | Build a topical map.
Dextromethorphan is a cough suppressant used in many cough and cold medicines. In 2022, the US Food and Drug Administration (FDA) approved the combination dextromethorphan/bupropion to serve as a rapid-acting antidepressant in people with major depressive disorder.
The analysis highlights History, Community, Culture and Applications as prominent areas in the source structure around Dextromethorphan.
Source areas are shown by the number of related topics found in each part of the analysis. Use smaller areas too: they can reveal specialized angles and content gaps.
Smaller areas are not necessarily less important. They contain fewer connections in this analysis and can be useful for finding specialized angles or coverage gaps.
High-confidence facts extracted from structured source data. Use them as anchors for further research.
Browse the complete topic structure, not only the most central items. Less prominent entities and concepts can reveal missing angles, specialized context and useful research gaps. Each item opens a new analysis centered on that subject.
Deeper signals for content research, entity SEO and topical coverage. The plain-language headings explain what each technical view is useful for.
The extracted context around Dextromethorphan shows recurring relationship patterns in the source. For example, Dextromethorphan → As, CIA-funded, Dextrotussion, During, FDA, Hoffmann-La Roche, In, Romilar, Swiss, The, US, US Navy, Vicks-44 Another extracted example is Dextromethorphan → At, Cough, CYP2D6, Following, It, P450, Study, The, The International Society. Use these groups to spot repeated connection types before inspecting the individual relationships.
Use these terms to understand the vocabulary surrounding the topic, not as a checklist for keyword stuffing.
drug cyp2d6 effects dissociative use major receptor dextrorphan serotonin combination approved metabolite doses cough nmda used medications including also number
TTTA extracted 136 structured relationships around Dextromethorphan. Examples in this analysis include Dextromethorphan → 3D model (JSmol) → Interactive image and Dextromethorphan → Addiction liability → Low–moderate. The table shows each extracted connection, where it came from and its confidence.
| Subject | Predicate | Object | Confidence | Src |
|---|---|---|---|---|
| Dextromethorphan | 3D model (JSmol) | Interactive image | 1.00 | infobox |
| Dextromethorphan | Addiction liability | Low–moderate | 1.00 | infobox |
| Dextromethorphan | AHFS/Drugs.com | Monograph | 1.00 | infobox |
| Dextromethorphan | ATC code | R05DA09 (WHO) | 1.00 | infobox |
| Dextromethorphan | Bioavailability | 11% | 1.00 | infobox |
| Dextromethorphan | CAS Number | 125-71-3 Y | 1.00 | infobox |
| Dextromethorphan | ChEBI | CHEBI:4470 N | 1.00 | infobox |
| Dextromethorphan | ChEMBL | ChEMBL52440 Y | 1.00 | infobox |
| Dextromethorphan | ChemSpider | 13109865 Y | 1.00 | infobox |
| Dextromethorphan | Chirality | Dextrorotatory enantiomer | 1.00 | infobox |
| Dextromethorphan | CompTox Dashboard (EPA) | DTXSID3022908 | 1.00 | infobox |
| Dextromethorphan | Drug class | Antitussive; Serotonin–norepinephrine reuptake inhibitor; NMDA receptor antagonist; Dissociative hallucinogen | 1.00 | infobox |
| Dextromethorphan | DrugBank | DB00514 Y | 1.00 | infobox |
| Dextromethorphan | Duration of action | 3–8 hours | 1.00 | infobox |
| Dextromethorphan | ECHA InfoCard | 100.004.321 | 1.00 | infobox |
| Dextromethorphan | Elimination half-life | 2–4 hours (extensive metabolizers); 24 hours (poor metabolizers) | 1.00 | infobox |
| Dextromethorphan | Excretion | Kidney | 1.00 | infobox |
| Dextromethorphan | Formula | C18H25NO | 1.00 | infobox |
| Dextromethorphan | IUPHAR/BPS | 6953 | 1.00 | infobox |
| Dextromethorphan | KEGG | D03742 Y | 1.00 | infobox |
| Dextromethorphan | Legal status | AU: S2 (Pharmacy medicine) | 1.00 | infobox |
| Dextromethorphan | Legal status | CA: OTC | 1.00 | infobox |
| Dextromethorphan | Legal status | UK: P (Pharmacy medicines) | 1.00 | infobox |
| Dextromethorphan | Legal status | US: OTC | 1.00 | infobox |
| Dextromethorphan | Legal status | UN: Unscheduled | 1.00 | infobox |
| Dextromethorphan | Legal status | SE: Förteckning V | 1.00 | infobox |
| Dextromethorphan | License data | US DailyMed: Dextromethorphan | 1.00 | infobox |
| Dextromethorphan | MedlinePlus | a682492 | 1.00 | infobox |
| Dextromethorphan | Melting point | 111 °C (232 °F) | 1.00 | infobox |
| Dextromethorphan | Metabolism | Liver enzymes: major CYP2D6, minor CYP3A4, and minor CYP3A5 | 1.00 | infobox |
The concept neighborhoods around Dextromethorphan bring nearby vocabulary together. In this analysis, examples include Drug, Effects and Dextrorphan. Use the clusters to find adjacent concepts and terminology that may deserve separate research.
For Dextromethorphan, one of the stronger structural bridges in this analysis connects Dextromethorphan with Overview. Bridges highlight paths between different parts of the map and can reveal research angles that are easy to miss in a flat list.
TTTA analyzes the structure around Dextromethorphan to surface related topics, entities, relationships, concept neighborhoods and bridge connections. Use the map to explore areas such as History, Community, Culture & Applications, including less central topics that may reveal useful research gaps. Automatically extracted connections are research leads rather than rewritten encyclopedia content.
Source: Wikipedia — Dextromethorphan · EN edition · Analysis: TopicsToTalkAbout